Related Experiment Video
Updated: Jul 4, 2025

05:31
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
5.6K
Performance of node reporting and data system (node-RADS): a preliminary study in cervical cancer.
Qingxia Wu1, Jianghua Lou1, Jinjin Liu1
1Department of Medical Imaging, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, No. 7 Weiwu Road, Zhengzhou, Henan, 450003, China.
BMC Medical Imaging
|January 26, 2024
Summary
The Node Reporting and Data System (Node-RADS) shows effectiveness in predicting lymph node metastasis (LNM) in cervical cancer patients, particularly for higher scores. However, lower Node-RADS scores did not accurately reflect the low probability of LNM.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- The Node Reporting and Data System (Node-RADS) is a standardized approach for evaluating lymph nodes (LNs) across various anatomical locations.
- This study focuses on assessing the diagnostic utility of Node-RADS specifically in the context of cervical cancer.
Purpose of the Study:
- To evaluate the diagnostic performance of the Node-RADS in predicting lymph node metastasis (LNM) in patients with cervical cancer.
- To determine the accuracy of Node-RADS scores in identifying LNM at both the lymph node and patient levels.
Main Methods:
- Retrospective analysis of 81 cervical cancer patients who underwent radical hysterectomy and lymph node dissection.
- Preoperative MRI scans were independently reviewed by two radiologists using the Node-RADS criteria.
- Statistical analyses, including Chi-square, Fisher's exact tests, ROC curve analysis, and AUC calculations, were performed to assess diagnostic performance.
Main Results:
- Lymph node metastasis (LNM) rates varied by anatomical region, with the highest rates in the external iliac (21.0%) and internal iliac (19.8%) regions.
- At the patient level, increasing Node-RADS scores correlated with higher LNM rates, ranging from 26.1% for score 1 to 90.9% for score 5.
- The optimal cut-off value for Node-RADS at both patient and LN levels was determined to be >3, yielding the best AUC and accuracy.
Conclusions:
- Node-RADS demonstrates effectiveness in predicting high likelihood of LNM for scores 4 and 5.
- Lower Node-RADS scores (1 and 2) showed higher-than-expected LNM rates (>25%), indicating a potential discrepancy with the system's intended probability stratification.
- Further refinement or validation may be needed for lower Node-RADS scores to improve their predictive accuracy in cervical cancer.

